首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Differential Effects of 5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoromethylindone(SB 243213)on 5-Hydroxytryptamine_(2c)Receptor-Mediated Responses
【24h】

Differential Effects of 5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoromethylindone(SB 243213)on 5-Hydroxytryptamine_(2c)Receptor-Mediated Responses

机译:5-甲基-1-[[[2-[(2-甲基-3-吡啶基)氧基] -5-吡啶基]氨基甲酰基] -6-三氟甲基茚酮(SB 243213)对5-羟基色胺_(2c)受体介导的差异作用回应

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoromethylindone(SB 243213)is a selective,high-affinity 5-hydroxytryptamine(serotonin)_(2c)receptor ligand that has been previously characterized as a competitive 5-HT_(2c)receptor antagonist that has a long duration of activity in vivo.It is active in two preclinical models of anxiety and has an improved anxiolytic profile compared with benzodiazepines.In this study,we further characterized the pharmacological properties of SB 243213 by measuring its effects on each of multiple responses coupled to the 5-HT_(2c)receptor.In Chinese hamster ovary cells,SB 243213 was an inverse agonist for the phospholipase A_2 response,for guanosine 5'-O-(3-[~(35)S]thio)triphosphate binding,for reduction of constitutive desensitization,and for enhancement of dopamine release in the rat nucleus accumbens,with relative efficacies of 0.6,1,1,and 0.6,respectively.However,for the phospholipase C(PLC)signaling cascade,SB 243213 behaved as an antagonist.Although SB 243213 was previously characterized as a competitive antagonist for the PLC response,the magnitude of the dextral shift of the 5-HT concentration-response curve was time-dependent,and the maximal PLC response to 5-HT was decreased,probably as a result of the slow dissociation rate of SB 243213(initial dissociation rate was 3.2 times slower than SB206553,a prototypical 5-HT_(2c)receptor inverse agonist).Taken together,these data show that the pharmacological characteristics of SB 243213 at the 5-HT_(2c)receptor differ depending upon the response measured,and they support the hypothesis that different drugs,acting at the same receptor subtype,can differentially regulate multiple cellular signaling systems.
机译:5-甲基-1-[[[2-[(2-甲基-3-吡啶基)氧基] -5-吡啶基]氨基甲酰基] -6-三氟甲基茚酮(SB 243213)是一种选择性的,高亲和力的5-羟基色胺(5-羟色胺) _(2c)受体配体先前被表征为竞争性5-HT_(2c)受体拮抗剂,在体内具有很长的持续时间,在两个临床前焦虑模型中均具有活性,并且与苯并二氮杂compared相比具有改善的抗焦虑特性在这项研究中,我们通过测量SB 243213对与5-HT_(2c)受体偶联的多种应答中的每一种的作用来进一步表征其药理特性。在中国仓鼠卵巢细胞中,SB 243213是磷脂酶A_2的反向激动剂。响应,对于鸟苷5'-O-(3- [〜(35)S]硫)三磷酸结合,减少结构性脱敏,增强大鼠伏隔核中多巴胺的释放,相对效率为0.6,1, 1和0.6分别。但是,对于磷脂酶C(PLC)信号级联,SB 243213表现为尽管SB 243213以前被认为是PLC反应的竞争性拮抗剂,但5-HT浓度-响应曲线的右旋位移大小随时间而变,而对5-HT的最大PLC反应却降低了,可能是由于SB 243213的解离速率慢(初始解离速率比典型的5-HT_(2c)受体反向激动剂SB206553慢3.2倍)。综上所述,这些数据表明SB 243213的药理特性5-HT_(2c)受体根据所测得的反应而有所不同,它们支持以下假设:作用于同一受体亚型的不同药物可以差异地调节多个细胞信号系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号